| Literature DB >> 28772991 |
Janette Alba1,2, Ricardo Navarro3, Imelda Saucedo4, Thierry Vincent5, Eric Guibal6.
Abstract
The decontamination of dilute industrial effluents is a critical challenge for decreasing the environmental impact of mining and metallurgical activities. As an alternative to conventional processes, new extractant impregnated resins (EIRs) have been synthesized by the immobilization of Cyanex 301 and Cyanex 302 in alginate capsules using two different procedures (matrix-type immobilization vs. mononuclear encapsulation). These materials have been tested for Pb(II) sorption from acidic solutions. The Langmuir equation fitted well the sorption isotherms and the maximum sorption capacities vary between 24 and 80 mg·g-1 at pH 1, depending on the type and loading of the extractant in the EIR. Uptake kinetics were controlled by the resistance to intraparticle diffusion; though both the Crank equation (intraparticle diffusion) and pseudo-second order rate equation equally fitted uptake profiles. The amount of extractant immobilized in mononuclear capsules is lower than in matrix-type beads; this leads to lower sorption capacities but slightly better mass transfer properties. The balance between the advantages and drawbacks of the different systems makes more promising matrix-type capsules. The desorption of Pb(II) is possible using 1 M HNO₃ solutions: metal ions were completely desorbed. However, the probable oxidation of the extractants (conversion to oxidized forms more sensitive to pH) reduces the sorption efficiency when they are re-used.Entities:
Keywords: Cyanex 301; Cyanex 302; desorption; lead; matrix-encapsulation; mononuclear encapsulation; sorption isotherms; uptake kinetics
Year: 2017 PMID: 28772991 PMCID: PMC5554015 DOI: 10.3390/ma10060634
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Characteristics of EIRs (Cyanex content and capsule size)—Effect of extractant loading, bead size, and mode of immobilization (N: mononuclear capsule; M: matrix immobilization).
| Extractant | Mode | Extractant Concentration * (% v/v) | Size | Cyanex Content | Cyanex Content | Capsule Size (µm) |
|---|---|---|---|---|---|---|
| C301 | M | 25 | - | 144.0 ± 2.5 | 446 ± 8 | 623 ± 14 |
| C301 | M | 50 | L | 338.9 ± 10.8 | 1051 ± 33 | 1846 ± 39 |
| C301 | M | 50 | S | 290.2 ± 4.7 | 900 ± 15 | 724 ± 19 |
| C301 | N | 50 | - | 93.9 ± 4.5 | 291 ± 14 | 1110 ± 31 |
| C302 | M | 50 | - | 314.5 ± 9.0 | 1026 ± 29 | 1430 ± 46 |
| C302 | M | 75 | - | 480.9 ± 25.3 | 1569 ± 8 | 1378 ± 19 |
| C302 | N | 50 | - | 55.8 ± 2.1 | 182 ± 7 | 876 ± 25 |
| C302 | N | 75 | - | 203.8 ± 5.0 | 665 ± 16 | 1034 ± 54 |
* Cyanex concentration in organic phase (kerosene).
Figure 1Effect of HCl concentration on the sorption of Pb(II) using Cyanex 301 and Cyanex 302 encapsulated in alginate mononuclear capsules (sorbent dosage, SD: 2 g·L−1; contact time: 4 days; T: 20 °C; C0: 50 mg·Pb·L−1; extractant concentration in kerosene: 50% v/v; agitation speed, v: 150 rpm).
Figure 2Pb(II) sorption isotherms using Cyanex 301 (a) and Cyanex 302 (b) encapsulated in alginate capsules (M: matrix-type capsules; N: mononuclear capsules) (solid lines: modeling of sorption isotherms with the Langmuir equation and coefficients reported in Table 2) (CHCl: 0.1 M; contact time: 4 days; T: 20 °C; v: 150 rpm).
Parameters of the Langmuir equation for Pb(II) sorption using Cyanex 301 and Cyanex 302 immobilized in alginate capsules.
| Sorbent | Cyanex Content | Cyanex/Pb(II) (mol/mol) | ||||
|---|---|---|---|---|---|---|
| C301-M-25 | 446 ± 8 | 48.3 | 233 | 0.445 | 0.999 | 1.91 |
| C301-M-50L | 1051 ± 33 | 69.3 | 334 | 5.96 | 0.999 | 3.14 |
| C301-M-50S | 900 ± 15 | 78.6 | 379 | 3.44 | 0.999 | 2.37 |
| C301-N-50 | 291 ± 14 | 36.3 | 175 | 1.06 | 0.998 | 1.66 |
| C302-M-50 | 1026 ± 29 | 35.1 | 169 | 1.58 | 0.999 | 6.06 |
| C302-M-75 | 1569 ± 8 | 49.5 | 239 | 1.83 | 0.997 | 6.57 |
| C302-N-75 | 665 ± 16 | 24.2 | 117 | 0.47 | 0.998 | 5.69 |
Figure 3Pb(II) uptake kinetics using Cyanex 301 and Cyanex 302 immobilized in alginate capsules (M: matrix-type capsule; N: mononuclear capsule) (solid lines: modeling of uptake kinetics with the RIDE—Crank equation—and coefficients reported in Table 3) (C0: 170 mg·Pb·L−1; SD: 2 g·L−1; CHCl: 0.1 M; v: 150 rpm; T: 20 °C).
Figure 4Pb(II) uptake kinetics using Cyanex 301 and Cyanex 302 immobilized in alginate capsules (M: matrix-type capsule; N: mononuclear capsule) (solid lines: modeling of uptake kinetics with the PFORE - and coefficients reported in Table 4) (C0: 170 mg·Pb·L−1; SD: 2 g·L−1; CHCl: 0.1 M; v: 150 rpm; T: 20 °C).
Figure 5Pb(II) uptake kinetics using Cyanex 301 and Cyanex 302 immobilized in alginate capsules (M: matrix-type capsule; N: mononuclear capsule) (solid lines: modeling of uptake kinetics with the PSORE - and coefficients reported in Table 4) (C0: 170 mg·Pb·L−1; SD: 2 g·L−1; CHCl: 0.1 M; v: 150 rpm; T: 20 °C).
Parameters of the RIDE model (Crank equation) for Pb(II) sorption using Cyanex 301 and Cyanex 302 immobilized in alginate capsules.
| Sorbent | Cyanex Content | MSR | |
|---|---|---|---|
| C301-M-25 | 446 ± 8 | 7.95 | 0.077 |
| C301-M-50L | 1051 ± 33 | 1.60 | 0.036 |
| C301-M-50S | 900 ± 15 | 0.27 | 0.078 |
| C301-N-50 | 291 ± 14 | 9.26 | 0.233 |
| C302-M-50 | 1026 ± 29 | 2.40 | 0.049 |
| C302-M-75 | 1569 ± 8 | 7.13 | 0.050 |
| C302-N-75 | 665 ± 16 | 3.20 | 0.108 |
MSR: mean square of residuals.
Parameters of the PFORE and PSORE models for Pb(II) sorption using Cyanex 301 and Cyanex 302 immobilized in alginate capsules.
| Sorbent | PFORE | PSORE | ||||||
|---|---|---|---|---|---|---|---|---|
| MSR | MSR | |||||||
| C301-M-25 | 446 | 42.94 | 40.13 | 5.83 | 2.67 | 41.88 | 2.05 | 0.804 |
| C301-M-50L | 1051 | 64.76 | 61.60 | 0.42 | 25.0 | 65.03 | 0.10 | 8.016 |
| C301-M-50S | 900 | 76.88 | 73.06 | 2.26 | 17.0 | 76.99 | 0.45 | 1.333 |
| C301-N-50 | 291 | 29.65 | 28.94 | 1.15 | 0.50 | 31.17 | 0.53 | 2.956 |
| C302-M-50 | 1026 | 30.62 | 29.25 | 1.89 | 1.31 | 30.77 | 0.99 | 0.666 |
| C302-M-75 | 1569 | 45.63 | 43.25 | 1.81 | 4.74 | 45.57 | 0.62 | 1.111 |
| C302-N-75 | 665 | 24.69 | 22.46 | 3.10 | 1.06 | 23.60 | 1.96 | 0.831 |
Mean Cyanex content, qHA: (µmol g−1); qe,exp, qe,1, qe,2: mg·Pb·g−1; k1: min−1; k2: g·mg−1·min−1; MSR: mean square of residuals.
Selection of the eluent for the desorption of Pb(II) from Cyanex 301 and Cyanex 302 immobilized in alginate capsules.
| Sorbent | Desorption Efficiency (%) | ||
|---|---|---|---|
| 0.1 M HNO3 | 1 M HNO3 | 1 M Thiourea/1 M HCl | |
| C301-M-25 | 56.1 | >99.9 | 88.2 |
| C302-M-50 | 39.0 | >99.9 | 83.1 |
| C302-N-75 | 78.0 | >99.9 | 85.9 |
Operating conditions—sorption and desorption: SD: 2 g·L−1; t: 24 h; v: 150 rpm; T: 20 °C/sorption: C0: 130 mg·Pb·L−1 except for C301-M-25 with C0: 200 mg·Pb·L−1.
Figure 6Comparison of Pb(II) sorption and desorption kinetic profiles for C302-M-50 sorbent.
Efficiency of sorption and desorption (%) for three successive cycles for Pb(II) recovery using Cyanex 301 and Cyanex 302 immobilized in alginate capsules.
| Sorbent | Cycle # 1 | Cycle # 2 | Cycle # 3 | |||
|---|---|---|---|---|---|---|
| Sorption | Desorption | Sorption | Desorption | Sorption | Desorption | |
| C301-M-25 | 35.5 | 97.7 | 2.9 | 94.6 | 2.1 | 93.5 |
| C302-M-50 | 55.8 | 99.5 | 4.6 | 90.5 | 5.8 | 70.9 |
| C302-N-75 | 33.2 | 98.6 | 4.9 | 6.6 | - | - |
Operating conditions—sorption and desorption: SD: 2 g·L−1; t: 24 h; v: 150 rpm; T: 20 °C/sorption: C0: 130 mg·Pb·L−1 except for C301-M-25 with C0: 200 mg·Pb·L−1; rinsing step between each cycle by contact with 0.01 M HCl solution for 5 min.